Open Accessibility Menu

Carteret Health Care Treatment Clinic to Treat Covid-19

Carteret Health Care is excited to share that we are offering a cutting-edge monoclonal antibody treatment for our community. This outpatient treatment helps decrease the likelihood of someone developing severe COVID-19 symptoms that could lead to hospitalization.

Carteret Health Care Treatment Clinic, located at 3601 Medical Park, allows COVID-19 positive individuals to receive emergency use of the Monoclonal Antibodies bamlanivimab (Eli-Lilly) and casirvimab & imdevmab (Regeneron) as noted by the FDA. This is for adults and pediatric patients with positive results of direct SARS-CoV-2 viral testing who are at high risk for progressing to severe COVID-19 and/or hospitalization. To be eligible, a person must test positive or display symptoms within 10 days of the infusion and be at high risk for becoming severely ill due to age or underlying health conditions.

Who is high risk?

  • You are 65 years of age or older.
  • You are 55 years of age or older AND have
    • Cardiovascular disease, OR
    • Hypertension, OR
    • Chronic obstructive pulmonary disease/other chronic respiratory disease.
  • Have a body mass index (BMI) greater than or equal to 35
  • Have chronic kidney disease
  • Have diabetes
  • Have immunosuppressive disease
  • Are currently receiving immunosuppressive treatment

“This treatment can help some folks avoid having to go to the hospital” shared Dr. Clyde Brooks, Vice President Medical Staff Services. “This is another example of how Carteret Health Care strives to keep our community healthy and safe.”

Contact your primary care physician or call Carteret Health Care at 252-499-8633 to see if you are eligible for the Monoclonal Antibody treatment. Infusions are offered at Carteret Health Care in the outpatient setting and appointments last about 2 hours.

To learn just where you fall in the vaccination plan, visit

Feel free to visit our website at or the Mayo Clinic’s Patient Health Library at